New immunotherapy drugs target two evasive cancer-driving proteins

3D holographic microscopy powered by deep-learning deciphers cancer immunotherapy

The unveiling of a novel mechanism of resistance to immunotherapy targeting HER2

Handcuffing the culprit cancer: Immunotherapy for cold tumors with trispecific antibody